Pill Identifier - Aspirin 81 mg Delayed Release Oral Tablet

Overview	Aspirin 81 mg Delayed Release Oral Tablet is a round shaped, yellow, delayed release tablet that is approximately 10 mm in size. It has one score and can be broken into two pieces. It is imprinted with "E", "HEART", and "81" and is supplied by Chain Drug Consortium, LLC.
Drug Name	Aspirin
Dosage Form	Delayed Release Tablet
Imprint(s)	E, HEART, 81
Pill Size	10 mm
Color	Yellow
Shape	Round
Score	1
DEA Schedule (Potential for Drug Abuse)	Not Scheduled

Active Ingredient(s)	Aspirin
Inactive Ingredient(s)	Diacetylated Monoglycerides, Anhydrous Lactose, Carnauba Wax, Silicon Dioxide, Starch, Corn, Croscarmellose Sodium, D&C Yellow No. 10, Hypromelloses, Hypromellose Phthalate, Ferric Oxide Yellow, Methacrylic Acid - Methyl Methacrylate Copolymer, Cellulose, Microcrystalline, Mineral Oil, Polyethylene Glycol 400, Polysorbate 80, Povidones, Propylene Glycol, Dimethicone, Sodium Bicarbonate, Sodium Hydroxide, Sodium Lauryl Sulfate, Stearic Acid, Talc, Titanium Dioxide, Triacetin, Triethyl Citrate, FD&C Yellow No. 6

Active Ingredient(s)

Aspirin

Inactive Ingredient(s)

Diacetylated Monoglycerides, Anhydrous Lactose, Carnauba Wax, Silicon Dioxide, Starch, Corn, Croscarmellose Sodium, D&C Yellow No. 10, Hypromelloses, Hypromellose Phthalate, Ferric Oxide Yellow, Methacrylic Acid - Methyl Methacrylate Copolymer, Cellulose, Microcrystalline, Mineral Oil, Polyethylene Glycol 400, Polysorbate 80, Povidones, Propylene Glycol, Dimethicone, Sodium Bicarbonate, Sodium Hydroxide, Sodium Lauryl Sulfate, Stearic Acid, Talc, Titanium Dioxide, Triacetin, Triethyl Citrate, FD&C Yellow No. 6

RxNorm Concept Unique Identifier	308,416
National Drug Code	680160089
Marketing Category	OTC monograph final

Supplier	Chain Drug Consortium, LLC
References	The data for Aspirin 81 mg Delayed Release Oral Tablet was updated by the U.S National Library of Medicine on January 18, 2018. U.S. National Library of Medicine. Accessed June 8, 2019. https://www.nlm.nih.gov Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019. https://www.dea.gov/drug-scheduling Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019. https://www.fda.gov/industry/fda-resources-data-standards/structured-product-labeling-resources HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019. http://www.hl7.org/implement/standards/rim.cfm

Supplier

Chain Drug Consortium, LLC

References

The data for Aspirin 81 mg Delayed Release Oral Tablet was updated by the U.S National Library of Medicine on January 18, 2018.

U.S. National Library of Medicine. Accessed June 8, 2019. https://www.nlm.nih.gov
Drug Scheduling. United States Drug Enforcement Administration. Accessed June 8, 2019. https://www.dea.gov/drug-scheduling
Structured Product Labeling Resources. U.S. Food & Drug Administration. March 27, 2018. Accessed June 8, 2019. https://www.fda.gov/industry/fda-resources-data-standards/structured-product-labeling-resources
HL7 Reference Information Model. HL7 Interational. Accessed June 8, 2019. http://www.hl7.org/implement/standards/rim.cfm

Color:
Yellow
Score:
2
Shape:
Oval
Size:
20 - 25mm
Imprint(s): 475
Pill Image: